Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension.
about
Vitamin E for Alzheimer's dementia and mild cognitive impairmentAcceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient dietTargeting New Candidate Genes by Small Molecules Approaching Neurodegenerative DiseasesPharmacology of epigenetics in brain disordersSystematic review of safety and tolerability of a complex micronutrient formula used in mental healthNatural products and supplements for geriatric depression and cognitive disorders: an evaluation of the research.Vitamin E for Alzheimer's dementia and mild cognitive impairment.A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy.Use of medical foods and nutritional approaches in the treatment of Alzheimer's disease.Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer's disease.Dietary deficiency increases presenilin expression, gamma-secretase activity, and Abeta levels: potentiation by ApoE genotype and alleviation by S-adenosyl methionine.Antioxidant approaches for the treatment of Alzheimer's disease.Use of vitamin and mineral supplements in long-term care home residents.Positive argument for debate in J Neural Transmission: Alzheimer's disease: are we intervening too late? Yes, by years if not decades.Efficacy and cost of micronutrient treatment of childhood psychosis.Implication of the nutritional and nonnutritional factors in the context of preservation of cognitive performance in patients with dementia/depression and Alzheimer disease.Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders.Prospects for the development of epigenetic drugs for CNS conditions.S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.Cognitive effects of adjunctive N-acetyl cysteine in psychosis.The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial.Health and nutrition promotion program for patients with dementia (NutriAlz): cluster randomized trial.S-Adenosylmethionine and Superoxide Dismutase 1 Synergistically Counteract Alzheimer's Disease Features Progression in TgCRND8 Mice.While I Still Remember: 30 Years of Alzheimer's Disease Research.Complex antioxidants in a randomized single-blinded study of memory in seniors.Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.Apple juice improved behavioral but not cognitive symptoms in moderate-to-late stage Alzheimer's disease in an open-label pilot study.Suboptimal Baseline Serum Vitamin B12 Is Associated With Cognitive Decline in People With Alzheimer's Disease Undergoing Cholinesterase Inhibitor Treatment.Vitamin E for Alzheimer's dementia and mild cognitive impairment
P2860
Q24202844-7A776984-4721-42E5-B3E8-6210EFB970D2Q24644293-E7CD5EEB-EDFD-4059-B8DF-42E25DD6FD5EQ26771812-59EDF492-E372-4A39-AD95-AF6452118961Q33673025-791374A9-993C-435F-BF8C-C41C891581B6Q33875871-9AC0435D-CB4E-4158-8AB1-94242F49DE06Q33946426-2A6F89CF-56B6-4EC8-9F15-EDC4536F1BB8Q34550138-150498DB-A963-49E8-9900-A7B637CB9FB9Q34865641-A52F0953-C8F8-44EB-9CF8-DAB2FAFC4DEFQ35193956-2B267101-E7A5-4FA3-BD18-D4E496C50792Q36566309-91A12425-B36A-4052-9D92-6EDC52880EA1Q37260956-3E6FF5C3-2C85-4030-A51D-459713BFBDDAQ37398555-AA8B6E5C-80E8-4C4B-829D-FF5314777561Q37768449-8CEA95B3-85B5-4109-B1EC-F89CA5A7540EQ37974976-ABD5C8B8-0ABD-4A6F-AC4F-0CA8FC13E582Q38025346-41393FAC-1FAF-45A2-B8F1-D81A02EE3F09Q38059199-0D88FD70-B67A-4D50-BE75-3F2ACB9F1C1EQ38148458-6DD70303-4E23-44DE-8BCD-2F55BE334499Q38229311-1E81E891-5300-4792-98EC-DC4602AD5DB0Q38497844-13FA140B-AD61-481B-B109-71C3D7780499Q38691239-6E6D8E13-7C70-41BC-B82A-FB1A3E386F69Q39147992-CB5ABBB8-FCF6-44A3-9719-D20F651D2E7FQ42371638-BF8E024B-C902-4714-8B94-809DE29AA5BEQ44675719-752CBCEA-7D9C-45BB-B21D-971E43CC55A4Q47099731-99E98768-BD0F-4752-8DA9-63FF8948BF2AQ47563110-A26252F1-5B07-4CEE-B11C-440EB1A4A61AQ47768376-E6464789-E4AB-4C0E-BA2D-62B26EE9E69AQ50663391-8A282E5F-ECD4-4E0B-AC6A-BB602E6C59FFQ53308769-B7A37891-DA5A-4E52-9883-77B981E9A6D1Q54963522-41446413-C024-4DD7-A8C8-4577CA0F5CD4Q56092262-27E3CADB-1EA2-47C5-8EC6-4A14568DD0FF
P2860
Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Efficacy of a vitamin/nutriceu ...... 16-month caregiver extension.
@en
Efficacy of a vitamin/nutriceu ...... 16-month caregiver extension.
@nl
type
label
Efficacy of a vitamin/nutriceu ...... 16-month caregiver extension.
@en
Efficacy of a vitamin/nutriceu ...... 16-month caregiver extension.
@nl
prefLabel
Efficacy of a vitamin/nutriceu ...... 16-month caregiver extension.
@en
Efficacy of a vitamin/nutriceu ...... 16-month caregiver extension.
@nl
P2093
P2860
P356
P1476
Efficacy of a vitamin/nutriceu ...... 16-month caregiver extension.
@en
P2093
James Paskavitz
Ruth Remington
Shelly Rasmussen
Thomas B Shea
P2860
P304
P356
10.1177/1533317508325093
P407
P577
2008-12-01T00:00:00Z